Linked Data API

Show Search Form

Search Results

224735
star this property registered interest false more like this
star this property date less than 2015-03-03more like thismore than 2015-03-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Clinical Commissioning Groups: Cumbria more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what funding (a) in total and (b) per capita has been allocated for Cumbria Clinical Commissioning Group for each year from 2013-14 to 2019-20. more like this
star this property tabling member constituency Copeland more like this
star this property tabling member printed
Mr Jamie Reed more like this
star this property uin 226114 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2015-03-06more like thismore than 2015-03-06
unstar this property answer text <p>Clinical commissioning group (CCG) funding has not been decided beyond 2015/16. Notified revenue allocations and per capita allocations for Cumbria CCG are:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Allocation £000</p></td><td><p>Per capita £</p></td></tr><tr><td><p>2013/14</p></td><td><p><del class="ministerial">692,122</del></p><p><ins class="ministerial">663,133</ins></p></td><td><p><del class="ministerial">1,330</del></p><p><ins class="ministerial">1,274</ins></p></td></tr><tr><td><p>2014/15</p></td><td><p>677,324</p></td><td><p>1,299</p></td></tr><tr><td><p>2015/16</p></td><td><p>685,654</p></td><td><p>1,313</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>These figures exclude running cost and Better Care Fund allocations.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-03-06T14:39:07.327Zmore like thisremove minimum value filter
star this property question first ministerially corrected
less than 2015-03-19T18:02:16.817Zmore like thismore than 2015-03-19T18:02:16.817Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property previous answer version
48371
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
1503
unstar this property label Biography information for Mr Jamie Reed more like this
431742
star this property registered interest false more like this
star this property date less than 2015-11-23more like thismore than 2015-11-23
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Per Capita Costs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much NHS England spent per head on mental health in each year since 2008. more like this
star this property tabling member constituency Central Suffolk and North Ipswich more like this
star this property tabling member printed
Dr Poulter more like this
star this property uin 17404 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2015-11-26more like thismore than 2015-11-26
unstar this property answer text <p>NHS England was formed in April 2013.</p><br /><p>The table below shows actual expenditure by clinical commissioning groups (CCGs) on mental health in 2013/14 and 2014/15 and forecast spend in 2015/16. This does not include spending on mental health services directly commissioned by NHS England.</p><p>Total actual expenditure by on mental health by CCGs across all providers for 2013/14 and 2014/15 and the total forecast expenditure for 2015/16</p><br /><table><tbody><tr><td><p>2013/14 actual spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td><td><p>2014/15 actual spend (£ <ins class="ministerial">billion</ins><del class="ministerial">million</del>)</p></td><td><p>2015/16 forecast spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td></tr><tr><td><p>9.6</p></td><td><p>10.1</p></td><td><p>10.6</p></td></tr></tbody></table><br /><p><em>Source:</em> NHS England</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-11-26T16:25:03.7Zmore like thismore than 2015-11-26T16:25:03.7Z
star this property question first ministerially corrected
less than 2015-12-02T14:16:07.33Zmore like thismore than 2015-12-02T14:16:07.33Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property previous answer version
32352
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
3932
unstar this property label Biography information for Dr Dan Poulter more like this
522126
star this property registered interest false more like this
star this property date less than 2016-05-26more like thismore than 2016-05-26
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Human Papillomavirus: Vaccination more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether the Medicines and Healthcare Products Regulatory Agency holds any clinical trial data for HPV vaccines which is not in the public domain. more like this
star this property tabling member constituency Denton and Reddish more like this
star this property tabling member printed
Andrew Gwynne more like this
star this property uin 38833 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2016-06-07more like thismore than 2016-06-07
unstar this property answer text <p>There are <del class="ministerial">two</del> <ins class="ministerial">three </ins>human papilloma virus vaccines licensed in the European Union: Cervarix<ins class="ministerial">,</ins> <del class="ministerial">and</del> <ins class="ministerial">Gardasil and </ins>Gardasil 9. These products are licensed centrally throughout Europe by the European Commission via the European Medicines Agency (EMA). Applicants for centrally authorised products are required to submit all relevant supporting clinical trials data, whether published or not, to the EMA directly and not to the Medicines and Healthcare products Regulatory Agency.</p><p> </p><p>Under current medicines legislation, the EMA database registers all EU-approved clinical trials of investigational medicinal products. Since March 2011 this information has been publicly accessible through the EU Clinical Trials Register (except adult Phase 1 trials). The EU Clinical Trials Register includes all EU-conducted trials since May 2004 when the Clinical Trials Directive was implemented and can be found here:</p><p> </p><p><a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">https://www.clinicaltrialsregister.eu/ctr-search/search</a></p><p> </p><p>Furthermore since July 2014 clinical trial sponsors have been required to provide a summary of their trial results uploaded onto the EU Clinical Trials Register within one year of their trial completing. There is a two year programme of back-loading underway to provide summaries of trial results for all trials on the Register back to when the EudraCT database was initiated in May 2004.</p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2016-06-07T10:57:37.313Zmore like thismore than 2016-06-07T10:57:37.313Z
star this property question first ministerially corrected
less than 2016-06-13T10:14:27.603Zmore like thismore than 2016-06-13T10:14:27.603Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property previous answer version
2228
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
1506
unstar this property label Biography information for Andrew Gwynne more like this
1139930
star this property registered interest false more like this
star this property date less than 2019-07-17more like thismore than 2019-07-17
star this property answering body
Department for Transport more like this
star this property answering dept id 27 more like this
star this property answering dept short name Transport more like this
star this property answering dept sort name Transport more like this
star this property hansard heading Petrol: Ethanol more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Transport, what assessment he has made of the potential merits of increasing the amount of ethanol in petrol sold to reduce carbon emissions. more like this
star this property tabling member constituency Newcastle-under-Lyme more like this
star this property tabling member printed
Paul Farrelly more like this
star this property uin 278404 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
unstar this property answer text <p>In 2018 the Department published a call for evidence on “E10 petrol, consumer protection and fuel pump labelling”. This document noted that using E10 (petrol containing up to 10% bioethanol) in place of E5 could reduce the net greenhouse gas emissions of a petrol vehicle by around two per cent.</p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2019-08-05T15:27:07.187Zmore like thismore than 2019-08-05T15:27:07.187Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
1436
unstar this property label Biography information for Paul Farrelly more like this
1140199
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department for Transport more like this
star this property answering dept id 27 more like this
star this property answering dept short name Transport more like this
star this property answering dept sort name Transport more like this
star this property hansard heading Electric Vehicles: North Cornwall more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Transport, what steps he is taking to increase the number of electric car charging points in North Cornwall. more like this
star this property tabling member constituency North Cornwall more like this
star this property tabling member printed
Scott Mann more like this
star this property uin 279104 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
unstar this property answer text <p>We want to encourage private sector investment to build and operate a self-sustaining public network that is affordable, reliable and accessible. In many cases, the market is best placed to identify the right locations for chargepoints and make improvements to the network and it is essential that viable commercial models are in place.</p><p> </p><p>The Government is also providing support through a number of schemes, which can be accessed across the country, including in North Cornwall. This includes schemes to help fund chargepoint infrastructure at people’s homes and workplaces and on residential streets. The Government’s on-street residential charging scheme offers grants to local authorities to help support this investment at local level. In February 2019, Cornwall County Council were awarded £94,000 through the Government’s Ultra Low Emission Taxi Infrastructure competition, to deliver five chargepoints dedicated to charging electric taxis and private hire vehicles.</p><p> </p><p>In conjunction with the Energy Savings Trust, this year the Office for Low Emission Vehicles has been running a series of roadshows for local authorities and public bodies across the UK, on best practice approaches to driving the uptake of ultra-low emission vehicles. The event in Bristol was well attended including local authority and public sector representatives from across the south west.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2019-08-05T15:39:33.983Zmore like thismore than 2019-08-05T15:39:33.983Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
4496
unstar this property label Biography information for Scott Mann more like this
1140609
star this property registered interest false more like this
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department for Transport more like this
star this property answering dept id 27 more like this
star this property answering dept short name Transport more like this
star this property answering dept sort name Transport more like this
star this property hansard heading Aviation: Exhaust Emissions more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Transport, whether his Department plans to ensure that all airlines operating in the UK have a carbon offset scheme to which customers can sign up. more like this
star this property tabling member constituency Newcastle-under-Lyme more like this
star this property tabling member printed
Paul Farrelly more like this
star this property uin 279385 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
unstar this property answer text <p>On 18 July 2019 the government launched a call for evidence on carbon offsetting for all transport modes, including aviation.</p><p> </p><p>This call for evidence explores how we might improve consumer understanding of the emissions from their journeys and their options to offset them, and if travel providers should be required to offer voluntary carbon offsets to their customers.</p><p>This is an area where we believe more information is needed to understand how any schemes could work successfully and we are looking forward to seeing the views and evidence that come through in response.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2019-08-05T14:29:59.833Zmore like thismore than 2019-08-05T14:29:59.833Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property previous answer version
131103
star this property answering member constituency Northampton North more like this
star this property answering member printed Michael Ellis more like this
star this property answering member 4116
star this property tabling member
1436
unstar this property label Biography information for Paul Farrelly more like this
224378
star this property registered interest false more like this
star this property date less than 2015-03-02more like thismore than 2015-03-02
star this property answering body
Department for Business, Innovation and Skills more like this
star this property answering dept id 26 more like this
star this property answering dept short name Business, Innovation and Skills more like this
star this property answering dept sort name Business, Innovation and Skills more like this
star this property hansard heading Manufacturing Industries: Trade Competitiveness more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Innovation and Skills, what analysis he has undertaken of the reasons for the fall of drug manufacturing output in the UK since 2010; what steps he plans to take to ensure that the UK pharmaceutical industry is globally competitive; and if he will make a statement. more like this
star this property tabling member constituency Hartlepool more like this
star this property tabling member printed
Mr Iain Wright more like this
star this property uin 225811 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-09more like thismore than 2015-03-09
unstar this property answer text <p>The global pharmaceutical sector along with other industries has faced challenges in coping with the economic downturn and global squeeze on prices. Pharmaceutical global restructuring has resulted in a significant number of plant closures in Europe including in the UK due to industry-wide overcapacity in manufacturing, expiry of patents on some of the medicines manufactured in the UK and slow growth of the European pharmaceutical market over the last few years, due to budget constraints. The figures are also partly due to the pharmaceutical manufacturing industry moving from a focus on small molecules to biological products, which require different manufacturing plants and capabilities.</p><p> </p><p>We are working with the sector, in particular through the Medicines Manufacturing Industry Partnership, to respond to the opportunities and challenges it has identified. For example, the Medicines and Healthcare Products Regulatory Agency’s Innovation office published four case studies that exemplify why the UK is a leading place to introduce new manufacturing processes. We have invested significantly in national centres such as the cell therapy and precision medicine catapults. We have also invested £55m in a Cell Therapy Manufacturing Centre, £38m in the National Biologics Manufacturing Centre and £28m in a National Formulation Centre. In addition, £13 million has been invested in 7 medicines manufacturing projects under the Regional Growth Fund, leveraging an £108m in private sector investment.</p><p> </p><p> </p><p> </p><p>These initiatives will help us to develop advanced medicines manufacturing, which should enable us to build new industries in areas such as cell and gene therapies. The Life Sciences Strategy launched in December 2011 set the foundations for this renewal. We estimate that since then at least £3.5 billion inward investment into the UK has been secured, creating over 11,000 new jobs.</p><p> </p><p> </p><p> </p><p>Recently, Glaxo SmithKline and Astra Zeneca have both made significant commitments to invest in manufacturing in the UK. In addition, non UK domiciled companies have recognised the opportunity of manufacturing in the UK, with Fujifilm Diosynth, opening a new manufacturing facility in October 2013 and Eisai opening its new packaging facility in November 2014.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-03-09T16:14:03.077Zmore like thismore than 2015-03-09T16:14:03.077Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
1478
unstar this property label Biography information for Mr Iain Wright more like this
224467
star this property registered interest false more like this
star this property date less than 2015-03-02more like thismore than 2015-03-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Brain Cancer: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps the Government has taken to improve brain cancer patients' access to cancer drugs. more like this
star this property tabling member constituency Windsor more like this
star this property tabling member printed
Adam Afriyie more like this
star this property uin 225805 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-09more like thismore than 2015-03-09
unstar this property answer text <p>The Government is committed to ensuring that patients have access to effective treatments, including those for brain cancers, on terms that represent value to the National Health Service and the taxpayer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NICE has recommended the following drugs for brain cancers as treatment options, subject to certain clinical criteria, in its technology appraisal guidance published in June 2007:</p><p> </p><p> </p><p> </p><p>- temozolomide (Temodal) for the treatment of newly diagnosed glioblastoma multiforme (GBM); and</p><p> </p><p> </p><p> </p><p>- carmustine (Gliadel) implants, for the treatment of newly diagnosed high-grade glioma.</p><p> </p><p> </p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance.</p><p> </p><p><em> </em></p><p> </p><p>Where a drug to treat brain cancer is not routinely available on the NHS, patients may be able to access it through the Cancer Drugs Fund. Bevacizumab (Avastin) is available for the third line treatment of low grade paediatric gliomas through the Fund.</p><p> </p><p> </p><p> </p><p>We are also commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-03-09T12:44:29.193Zmore like thismore than 2015-03-09T12:44:29.193Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
1586
unstar this property label Biography information for Adam Afriyie more like this
224729
star this property registered interest false more like this
star this property date less than 2015-03-03more like thismore than 2015-03-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Brain: Diseases more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will fund research on using a skin test to detect hard-to-spot brain diseases. more like this
star this property tabling member constituency Upper Bann more like this
star this property tabling member printed
David Simpson more like this
star this property uin 226008 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-09more like thismore than 2015-03-09
unstar this property answer text <p>The Department's National Institute for Health Research welcomes funding applications for research into any aspect of human health, including tests for biological markers of brain diseases. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2015-03-09T12:44:58.793Zmore like thismore than 2015-03-09T12:44:58.793Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
1597
unstar this property label Biography information for David Simpson more like this
224731
star this property registered interest false more like this
star this property date less than 2015-03-03more like thismore than 2015-03-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Services: South Yorkshire more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, which schemes in Sheffield and South Yorkshire will be (a) cancelled, (b) delayed or (c) deferred as a result of the transfer of £197 million from the NHS Technology Fund budget for 2014-15 to the revenue budget. more like this
star this property tabling member constituency Sheffield South East more like this
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 225998 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-03-06more like thismore than 2015-03-06
unstar this property answer text <p>The Department has not cancelled, delayed or deferred any agreed funding for specific capital schemes in National Health Service trusts or foundation trusts.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 225995 more like this
star this property question first answered
less than 2015-03-06T14:49:13.513Zmore like thismore than 2015-03-06T14:49:13.513Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
star this property tabling member
394
unstar this property label Biography information for Mr Clive Betts more like this